Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review
Authors:
Open Access
- 6 April 2025
- journal article
- case report
- Published by Elsevier in The Breast
- Vol. 81, 104465
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (JR24/00024)
This publication has 47 references indexed in Scilit:
- Characterization of HER2‐low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort studyCancer, 2024
- Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide surveyClinical and Translational Oncology, 2024
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)Clinical and Translational Oncology, 2023
- Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancerAnnals of Oncology, 2023
- Drug-Induced Kounis Syndrome: Latest NoveltiesCurrent Treatment Options in Allergy, 2023
- Dissecting the biological heterogeneity of HER2-positive breast cancerThe Breast, 2021
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021Annals of Oncology, 2021
- Coronary Hypersensitivity Disorder: The Kounis SyndromeClinical Therapeutics, 2013
- Paclitaxel‐induced ST‐Segment ElevationsClinical Cardiology, 2009